IL6 and acute respiratory distress syndrome: Furthermore, in a model of LPS-induced Acute respiratory distress syndrome (ARDS), treatment with pyridostigmine reduced the number of macrophages and lymphocytes in bronchoalveolar lavage fluid and suppressed levels of TNFα, IL-1β, IL-6, and IFN-γ [45].